Scroll Top
Menu
Home
About us
Strategy
Team
Portfolio
BrainEver
Chronolife
GrAI Matter Labs
Prophesee
T-Heart
Tilak
Newsroom
Contact us
Newsroom
Events
(3)
News
(78)
Press releases
(84)
Archive
2023
2022
2021
2020
2019
2018
2017
2016
Clear Filters
TILAK HEALTHCARE winner of the Prix Galien 2020 e-Health category
December 18, 2020
TILAK HEALTHCARE winner of the Prix Galien 2020 e-Health category
Clear Filters
Chronolife chooses Mulliez-Flory to manufacture their connected textiles on an industrial scale
December 17, 2020
Chronolife chooses Mulliez-Flory to manufacture their connected textiles on an industrial scale
Tilak Healthcare inks a new partnership agreement in ophtalmology with Novartis to expand internationally (To promote OdySight®, an innovative vision monitoring technology)
December 8, 2020
Tilak Healthcare inks a new partnership agreement in ophtalmology with Novartis to expand internationally (To promote OdySight®, an innovative vision monitoring technology)
Clear Filters
Chronolife’s Nexkin Biometric T-Shirt Enables Continuous Real-Time Health Monitoring
December 1, 2020
Chronolife’s Nexkin Biometric T-Shirt Enables Continuous Real-Time Health Monitoring
Clear Filters
GrAI Matter Labs raises $14M for edge AI inferencing
November 30, 2020
GrAI Matter Labs raises $14M for edge AI inferencing
Medical monitoring: Chronolife partners with be-ys to optimize remote care of patients with chronic disease
November 24, 2020
Medical monitoring: Chronolife partners with be-ys to optimize remote care of patients with chronic disease
BrainEver Receives FDA Orphan Drug Designation for BREN-02, (human recombinant Engrailed 1) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
November 23, 2020
BrainEver Receives FDA Orphan Drug Designation for BREN-02, (human recombinant Engrailed 1) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Load More
